Clinical practice guidelines for BRCA1 and BRCA2 genetic testing
2021 · European Journal of Cancer · 173 citations
https://doi.org/10.1016/j.ejca.2020.12.023
J
Julie A. Vendrell
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
95
Papers
2.5K
Citations
25
h-index
41
i10-index
Julie A. Vendrell is an academic researcher from Université de Montpellier. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Lung Cancer Treatments and Mutations & Estrogen and related hormone effects. The author has an h-index of 25, co-authored 81 publications.
ORCID: 0000-0002-2071-6634Papers by this author
worksGenetic variability in MCF-7 sublines: evidence of rapid genomic and RNA expression profile modifications
2003 · BMC Cancer · 99 citations
https://doi.org/10.1186/1471-2407-3-13
MicroRNA-125b upregulation confers aromatase inhibitor resistance and is a novel marker of poor prognosis in breast cancer
2015 · Breast Cancer Research · 79 citations
https://doi.org/10.1186/s13058-015-0515-1
ZNF217 confers resistance to the pro-apoptotic signals of paclitaxel and aberrant expression of Aurora-A in breast cancer cells
2010 · Molecular Cancer · 51 citations
https://doi.org/10.1186/1476-4598-9-291
MelanoDB: A dataset of clinical and molecular features of patients with advanced melanoma treated with MAPK inhibitors
2025 · Scientific Data · 2 citations
https://doi.org/10.1038/s41597-025-05291-3
Gene expression profiling of hydroxy-tamoxifen resistance in breast cancer.
2001 · HAL (Le Centre pour la Communication Scientifique Directe) · 0 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat